Phathom Pharmaceuticals (PHAT) Non-Current Deffered Revenue (2022 - 2026)
Phathom Pharmaceuticals' Non-Current Deffered Revenue came in at $347.63 million for Q2 2026, up 0.2% from $347 million a year earlier but down 0.1% from the prior quarter.
Powered by 
Analysis
Phathom Pharmaceuticals (PHAT) Non-Current Deffered Revenue (2022 - 2026) Analysis & Trends
At the end of FY2025, Phathom Pharmaceuticals' Non-Current Deffered Revenue was $350.12 million, up 5.1% from FY2024.
- Non-Current Deffered Revenue has increased in each of the last three years, with a three-year compound annual growth rate of 47.3% (FY2022 to FY2025).
- Going back by year, Non-Current Deffered Revenue was $333.26 million in FY2024 (+11.2%), $299.82 million in FY2023 (+173.7%) and $109.53 million in FY2022.
- The five-year range for quarterly Non-Current Deffered Revenue is $109.53 million (Q4 2022) to $350.12 million (Q4 2025).
- Year-over-year, Non-Current Deffered Revenue has increased for nine consecutive quarters, with growth averaging 26.1% over the last eight quarters.
- The year-over-year growth in Non-Current Deffered Revenue has ranged between 0.2% (Q2 2026) and 173.7% (Q4 2023) over the last five years.
- Business Quant data shows PHAT's Non-Current Deffered Revenue at $347.9 million (Q1 2026), $350.12 million (Q4 2025) and $348.98 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Phathom Pharmaceuticals | 584.51 Mn | -55.45 Mn | 59.18 Mn | 347.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 347.63 Mn |
| Mar 31, 2026 | 347.90 Mn |
| Dec 31, 2025 | 350.12 Mn |
| Sep 30, 2025 | 348.98 Mn |
| Jun 30, 2025 | 347.00 Mn |
| Mar 31, 2025 | 343.81 Mn |
| Dec 31, 2024 | 333.26 Mn |
| Sep 30, 2024 | 322.39 Mn |
| Jun 30, 2024 | 321.19 Mn |
| Mar 31, 2024 | 302.53 Mn |
| Dec 31, 2023 | 299.82 Mn |
| Sep 30, 2023 | 123.40 Mn |
| Jun 30, 2023 | 119.80 Mn |
| Dec 31, 2022 | 109.53 Mn |
API Access
Phathom Pharmaceuticals Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=PHAT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "PHAT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=PHAT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();